GOSSAMER BIO, INC. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5d34084f-805e-4aec-b874-cb58ce3fa9e6/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-170.7M | 2025-01-01 – 2025-12-31 | evidence 0001728117-26-000017 |
| FY 2024 | $-59.9M | 2024-01-01 – 2024-12-31 | evidence 0001728117-25-000021 |
| FY 2023 | $-183.8M | 2023-01-01 – 2023-12-31 | evidence 0001728117-24-000019 |
| FY 2022 | $-218.6M | 2022-01-01 – 2022-12-31 | evidence 0001728117-23-000010 |
| FY 2021 | $-216.1M | 2021-01-01 – 2021-12-31 | evidence 0001728117-22-000019 |
| FY 2020 | $-234.0M | 2020-01-01 – 2020-12-31 | evidence 0001728117-21-000019 |
| FY 2019 | $-186.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-012323 |
| FY 2018 | $-149.0M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-012323 |
| FY 2017 | $-6.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-20-012323 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).